Immunological and preventive effects of COVID-19 vaccine against Omicron variant - a review of research progress
Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant in November 2021, the coronavirus diseases 2019 (COVID-19) epidemics caused by the variant has rapidly spread all over the world and the variant become the dominant strain in SARS-CoV-2 infections. Un...
Saved in:
Main Authors: | Zhi-qiang CAO (Author), Li LU (Author), Wei ZHANG (Author) |
---|---|
Format: | Book |
Published: |
Editorial Office of Chinese Journal of Public Health,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How to translate the knowledge of COVID‐19 into prevention of Omicron variants
by: Xiangdong Wang, et al.
Published: (2021) -
Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review
by: Yuxuan Du, et al.
Published: (2022) -
Chimeric mRNA-based COVID-19 vaccine induces protective immunity against Omicron and Delta variants
by: Qidong Hu, et al.
Published: (2022) -
Developing variant-adapted COVID-19 vaccines to improve protection against Omicron and other recent variants: a plain language summary
by: Shanti Pather, et al.
Published: (2024) -
Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review
by: Pradipta Paul, et al.
Published: (2023)